Skip to content
OpenCapital
Get started

CNO Financial Group CNO Supplemental health — Interest accretion rate

Other product segments

Long-term care
5.6%-0.5%
Traditional life
4.8%+0.8%
Medicare supplement
4.2%-2.8%

Other financials

Income statement

See full
Revenue$1.0B+2.5%
Net income$37.7M+75.3%
EPS (diluted)$0.39+85.7%

Balance sheet

See full
Cash & equivalents$1.2B+12.6%
Total debt$1.4B-41.0%
Total equity$2.5B-2.2%
Total assets$39.0B+4.1%

Cash flow

See full
Operating cash flow$148.8M+8.9%

Valuation

See full
Market cap$4.93B-7.9%

Profitability

See full
Net margin5.4%-2.2pp

Returns & leverage

See full
Return on equity9.7%-3.7pp
Debt / equity0.5×-0.4×

Where this comes from

Reported directly by CNO Financial Group in its filing.

Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitWeightedAverageInterestAccretionRate.

The official record: CNO Financial Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CNO Financial Group's supplemental health — interest accretion rate.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CNO Financial Group's supplemental health — interest accretion rate?
CNO Financial Group (CNO) reported supplemental health — interest accretion rate of 5% in Q1 2026.
How has CNO Financial Group's supplemental health — interest accretion rate changed year-over-year?
CNO Financial Group's supplemental health — interest accretion rate decreased by 0.4% year-over-year, from 5% to 5%.
What is the long-term trend for CNO Financial Group's supplemental health — interest accretion rate?
Over 3 years (2022 to 2025), CNO Financial Group's supplemental health — interest accretion rate has grown at a -0.7% compound annual growth rate (CAGR), from 20.3% to 19.8%.
What does supplemental health — interest accretion rate mean?
The effective interest rate used to calculate the accretion of insurance liabilities, reflecting the expected return on assets backing those liabilities. It is a key actuarial assumption that directly impacts the reported expense levels and the valuation of long-duration insurance contracts.